Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seromycin for Social Skills Training in PDD
NCT01086475Phase 3Completed
- Sponsor
- Indiana University
- Start
- Mar 2010
- Primary completion
- Jan 2014
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of d-cycloserine in pervasive developmental disorder (PDD), sponsored by Indiana University. Primary endpoint: Social Responsiveness Scale Change at 11 weeks. Started Mar 2010; status: completed.
02
Drugs
d-cycloserine
03
Conditions
pervasive developmental disorder (PDD)
Beyond the preview
Go deeper on NCT01086475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086475.